Kinlin L. Chao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kinlin L. Chao has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Abdul S. Yunus
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850
1 shared publication- Alexander K. Andrianov
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, USA
1 shared publication Alexander Marin
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850
1 shared publicationAndrezza Chagas
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850
1 shared publication- Brian G. Pierce
Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, U.S.A.
1 shared publication Eric A. Toth
Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850
1 shared publication
Latest Publications
- 1 March 2023
- Published by Springer Nature in Biomolecular NMR Assignments
- Vol. 17 (1) , 75-81
Backbone NMR assignment of the yeast expressed Fab fragment of the NISTmAb reference antibody
The monoclonal antibody (mAb) protein class has become a primary therapeutic platform for the production of new life saving drug products. MAbs are comprised of two domains: the antigen-binding fragment (Fab) and crystallizable fragment (Fc). Despite the success in the clinic, NMR assignments of the complete Fab domain have been elusive, in part due to problems in production of properly folded, triply-labeled 2H,13C,15N Fab domain. Here, we report the successful recombinant expression of a triply-labeled Fab domain, derived from the standard IgG1κ known as NISTmAb, in yeast. Using the 2H,13C,15N Fab domain, we assigned 94% of the 1H, 13C, and 15N backbone atoms.
- 1 March 2023
- Published by Springer Nature in Biomolecular NMR Assignments
- Vol. 17 (1) , 75-81
Backbone NMR assignment of the yeast expressed Fab fragment of the NISTmAb reference antibody
The monoclonal antibody (mAb) protein class has become a primary therapeutic platform for the production of new life saving drug products. MAbs are comprised of two domains: the antigen-binding fragment (Fab) and crystallizable fragment (Fc). Despite the success in the clinic, NMR assignments of the complete Fab domain have been elusive, in part due to problems in production of properly folded, triply-labeled 2H,13C,15N Fab domain. Here, we report the successful recombinant expression of a triply-labeled Fab domain, derived from the standard IgG1κ known as NISTmAb, in yeast. Using the 2H,13C,15N Fab domain, we assigned 94% of the 1H, 13C, and 15N backbone atoms.
- 11 January 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (3)
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer
Significance: Hepatitis C virus infects 1% of the world’s population, with no vaccine currently available. One vaccine candidate is the membrane-associated E1E2 envelope glycoprotein which has been used in clinical studies. However, a major challenge to both structural studies and rational vaccine design is high-yield production of homogenous E1E2. Production of E1E2 liberated from the membrane with native structure and antigenicity would thus represent a major advance. We describe the design and validation of a soluble, secreted E1E2 (sE1E2) antigen in which a scaffold replaces its transmembrane domains and enforces assembly. High-affinity sE1E2 binding to broadly neutralizing antibodies and to its receptor CD81, along with robust immunogenicity, makes this a promising platform for high-resolution structural characterization and vaccine development.
- 11 January 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (3)
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer
Significance: Hepatitis C virus infects 1% of the world’s population, with no vaccine currently available. One vaccine candidate is the membrane-associated E1E2 envelope glycoprotein which has been used in clinical studies. However, a major challenge to both structural studies and rational vaccine design is high-yield production of homogenous E1E2. Production of E1E2 liberated from the membrane with native structure and antigenicity would thus represent a major advance. We describe the design and validation of a soluble, secreted E1E2 (sE1E2) antigen in which a scaffold replaces its transmembrane domains and enforces assembly. High-affinity sE1E2 binding to broadly neutralizing antibodies and to its receptor CD81, along with robust immunogenicity, makes this a promising platform for high-resolution structural characterization and vaccine development.